Sagittarius Life Science (ROCO:3205) EV-to-Revenue

: 2.78 (As of Today)

View and export this data going back to 2005. Start your Free Trial

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Sagittarius Life Science's enterprise value is NT$1,225.1 Mil. Sagittarius Life Science's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was NT$440.5 Mil. Therefore, Sagittarius Life Science's EV-to-Revenue for today is 2.78.

The historical rank and industry rank for Sagittarius Life Science's EV-to-Revenue or its related term are showing as below:

ROCO:3205' s EV-to-Revenue Range Over the Past 10 Years
Min: 0.69 Med: 2.29 Max: 10.69
Current: 2.78

During the past 13 years, the highest EV-to-Revenue of Sagittarius Life Science was 10.69. The lowest was 0.69. And the median was 2.29.

ROCO:3205's EV-to-Revenue is ranked better than
71.58% of 1031 companies
in the Biotechnology industry
Industry Median: 7.7 vs ROCO:3205: 2.78

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-04-23), Sagittarius Life Science's stock price is NT$43.85. Sagittarius Life Science's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was NT$13.54. Therefore, Sagittarius Life Science's PS Ratio for today is 3.24.

Sagittarius Life Science EV-to-Revenue Historical Data

The historical data trend for Sagittarius Life Science's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sagittarius Life Science Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EV-to-Revenue

Get a 7-Day Free Trial

2.75

1.35

0.98

2.04

3.43

Sagittarius Life Science Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
EV-to-Revenue	Get a 7-Day Free Trial															2.04	2.12	3.04	2.49	3.43

Competitive Comparison

For the Biotechnology subindustry, Sagittarius Life Science's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sagittarius Life Science EV-to-Revenue Distribution

For the Biotechnology industry and Healthcare sector, Sagittarius Life Science's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Sagittarius Life Science's EV-to-Revenue falls into.

Sagittarius Life Science EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Sagittarius Life Science's EV-to-Revenue for today is calculated as:

EV-to-Revenue	=	Enterprise Value (Today)	/	Revenue (TTM)
	=	1225.081	/	440.46
	=	2.78

Sagittarius Life Science's current Enterprise Value is NT$1,225.1 Mil.
Sagittarius Life Science's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$440.5 Mil.

Sagittarius Life Science (ROCO:3205) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Sagittarius Life Science's PS Ratiofor today is calculated as:

PS Ratio	=	Share Price (Today)	/	Revenue per Share (TTM)
	=	43.85	/	13.541
	=	3.24

Sagittarius Life Science's share price for today is NT$43.85.
Sagittarius Life Science's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$13.54.

Sagittarius Life Science EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Sagittarius Life Science's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Sagittarius Life Science (ROCO:3205) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sagittarius Life Science Corp (ROCO:3205) » Definitions » EV-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 3, Park Street, 10-6th Floor, Nangang District, Taipei, TWN

Website

http://www.naturalbiokey.com

Sagittarius Life Science Corp is a Taiwan based company engaged in operating as a biotechnology and pharmaceutical company. Its business activity is to develop Chinese herbal medicines and supplements for the treatment of bone fractures, osteoporosis, wound healing and skin care.

Sagittarius Life Science (ROCO:3205) Headlines

No Headlines